Tag: Abbott

Abbott Granted Intoximeters Rights to Market Abbott’s SoToxaTM Mobile Test System

abbott
Abbott and Intoximeters announced an agreement for Intoximeters to market Abbott's SoToxaTM Mobile Test System – a handheld oral fluid roadside testing solution that rapidly and reliably detects recen...

FDA Approved New Blood and Plasma Screening Alinity™ s System

abbott
Abbott announced U.S. Food and Drug Administration (FDA) approval for its new blood and plasma screening Alinity™ s System. This new solution will bring the latest screening technology to U.S. blood a...

Abbott to Start Making Syringes, Nasal Drops in Vladimir Region

The U.S. pharmaceutical company Abbott which owns a 100% stake in Veropharm, and the Vladimir regional administration have signed a memorandum of cooperation. The agreement was signed on the sideli...

Abbott Launched Test To Detect Diabetes

blood-sugar
Abbott announced that its Afinion™ HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion AS100 Analyzer. The Afinion HbA1c Dx assay is the first and only rapid poin...

Abbott Announced New Data on Continuous Glucose Monitoring Technology

Abbott announced new data showing use of its FreeStyle Libre system, the company's revolutionary continuous glucose monitoring (CGM) technology, significantly reduced hemoglobin A1c (HbA1c) levels for...

Abbott to Cooperate with NIH on Brain Initiative

neuronet
Abbott today announced that it has partnered with the National Institutes of Health on the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) initiative to accelerate advancements i...

World’s First Point-of-Care HIV Test Received WHO PQ Approval

Abbott announced that m-PIMA™ HIV-1/2 VL, the world's first point-of-care viral load diagnostic test, has received the World Health Organization's Prequalification approval (WHO PQ). The test received...

Abbott Announced CE Mark for its Diagnostics System

Alinity m will allow labs to meet the growing demand for infectious disease testing by offering increased efficiency and market-leading speed and accuracy. Abbott announced today CE Mark for its Al...

FDA Expanded Approval for Abbott’s MitraClip™ Device

The world's first minimally invasive mitral valve repair device now approved to help difficult-to-treat heart failure patients with clinically significant secondary mitral regurgitation. Abbott ann...

Abbott and Novo Nordisk Team Up

Collaboration will enable insulin data to be shared between Novo Nordisk connected insulin pens and digital health tools compatible with FreeStyle Libre portfolio of products. Abbott and Novo Nordi...

Abbott and Novo Nordisk in Partnership

Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools...

Abbott localized full-cycle manufacturing of its drug at the Veropharm plant

Veropharm
Abbott presented a new production line to localize the full-cycle manufacturing of an Abbott drug to support women's reproductive health, which is in line with the strategic objectives of the government in Russia.

Strategic partnership between Veropharm and Bion: from R&D to manufacturing

abbott-verofarm
Veropharm (Abbott Group) announced the signing of Strategic Partnership Agreement with Bion